JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Tel: +1-832-696-8203
Email: [email protected]
Worldwide Distributors
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Animal models
Horses and ponies
Dosage form
0.2 mg/kg (p.o.)
Application
Avermectin B1 treatment resulted in a significant decrease in the average number of strongyle egg counts the 14, 28 and 42 days. Oral administration of this avermectin B1 formulation appeared to be very effective against the intestinal strongyles and Onchocera microfilaria. However, the duration of anti- strongyle activity was much shorter than that of ivermectin paste.
Other notes
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.
References:
[1]. Mogg TD, Pollitt CC, Willmore JP, Thompson H. Efficacy of avermectin B1 given orally against equine intestinal strongyles and Onchocera microfilaria. Aust Vet J. 1990 Nov;67(11):399-401. doi: 10.1111/j.1751-0813.1990.tb03026.x. PMID: 2085293.